BNTX Dividend: Biontech SE Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

BNTX Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	3,152	2,751	3,819	17,311	18,977	482
Revenue Growth (YoY)	4%	-28%	-78%	-9%	3,836.99%	342%
Cost of Revenue	453	415	599	2,995	2,912	59
Gross Profit	2,699	2,335	3,219	14,316	16,065	423
Selling, General & Admin	538	599	551	544	329	103
Research & Development	2,211	2,254	1,783	1,488	916	615
Operating Expenses	3,521	3,494	2,311	2,016	1,284	506
Other Non Operating Income (Expenses)	-7	-4	-2	-3	-22	-3
Pretax Income	-522	-677	1,186	12,954	15,046	-146
Income Tax Expense	49	-12	255	3,520	4,754	-161
Net Income	-571	-665	930	9,434	10,293	15
Net Income Growth	23%	-172%	-90%	-8%	68,520%	-108%
Shares Outstanding (Diluted)	239.16	240.4	242.7	250	260	253
Shares Change (YoY)	-2%	-1%	-3%	-4%	3%	20%
EPS (Diluted)	-2.38	-2.76	3.83	37.73	39.58	0.06
EPS Growth	25%	-172%	-90%	-5%	65,867%	-107%
Free Cash Flow	-1,094	-244	4,665	13,214	736	-98
Free Cash Flow Per Share	-4.57	-1.01	19.22	52.85	2.83	-0.38
Gross Margin	85.62%	84.87%	84.28%	82.69%	84.65%	87.75%
Operating Margin	-26.07%	-42.09%	23.77%	71.05%	77.88%	-17.01%
Profit Margin	-18.11%	-24.17%	24.35%	54.49%	54.23%	3.11%
Free Cash Flow Margin	-34.7%	-8.86%	122.15%	76.33%	3.87%	-20.33%
EBITDA	-439	-860	1,091	12,423	14,856	-43
EBITDA Margin	-13.92%	-31.26%	28.56%	71.76%	78.28%	-8.92%
D&A For EBITDA	383	298	183	123	75	39
EBIT	-822	-1,158	908	12,300	14,781	-82
EBIT Margin	-26.07%	-42.09%	23.77%	71.05%	77.88%	-17.01%
Effective Tax Rate	-9.38%	1.77%	21.5%	27.17%	31.59%	110.27%